Viewing nowGlipion Tablets (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
Youyoung Pharmaceutical Co., Ltd.

MFDS item code 201307042 · Approved 2013.04.23 · Insurance code 648203640
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to assist in the regulation of blood sugar levels in patients with type 2 diabetes. It is administered as an adjunct to diet and exercise therapies and can also be used as monotherapy. If blood sugar levels are not well-controlled, it may be taken in conjunction with other oral hypoglycemics or insulin. When sulfonylureas or metformin monotherapy are ineffective, this medication can be combined with metformin to improve blood sugar control. This helps effectively manage patients' blood sugar and maintain health.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. This medicine should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have shown better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the method described under Initial dose. That is, start treatment at 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered medicine should be taken into consideration. 4) Dose adjustment during treatment Blood glucose and/or urine glucose levels should be measured regularly while taking this medicine. Regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately ingesting sugar. Despite successful initial management of hypoglycemia with sulfonylurea medicines, hypoglycemia may recur. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate treatment and follow-up by a physician and, in some cases, hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. This medicine is administered at a dose of 8 mg once daily with the first meal, while insulin is initiated at a low dose and increased approximately once weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Periodic adjustment of the insulin dose is necessary while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylurea agents such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered in combination with metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be administered to patients with insulin-dependent diabetes or those in a state of diabetic ketoacidosis or coma. Patients with hypersensitivity to this medication or to sulfonylureas, sulfonamides should also not use it. It is also unsafe for individuals with severe liver or kidney damage, as well as pregnant or breastfeeding women. Patients with severe infections, before and after surgery, or with severe trauma are recommended to transition to insulin therapy. Patients with gastrointestinal disorders may be at risk of hypoglycemia due to improper food absorption, requiring caution. During initial dosing, the risk of hypoglycemia is high; therefore, blood sugar changes must be carefully monitored, especially in elderly patients or those with irregular meals or poor nutritional status. Alcohol consumers or individuals with diminished liver or kidney function may also have increased risk of hypoglycemia. This medication lowers blood sugar levels and may elicit hypoglycemic symptoms, which can include headaches, severe hunger, nausea, fatigue, confusion, drowsiness, and loss of consciousness, among other symptoms. In the event of hypoglycemia, consuming sugar-containing foods to quickly raise blood sugar levels is crucial. During treatment with this medication, liver abnormalities, blood abnormalities, and allergic reactions may occur, warranting immediate consultation with a doctor if any unusual symptoms arise. This medication should be taken regularly along with a proper diet and exercise program, and continuous monitoring of blood sugar levels is necessary. If taken with other medications, interactions may impact blood sugar control, so patients must inform their physician or pharmacist about any concurrent medications. Pregnant or breastfeeding women should not use this medication and should transition to insulin therapy if necessary. Safety in patients under 18 years has not been established, and dosage adjustments may be necessary for the elderly considering kidney function. In cases of overdose, severe hypoglycemia may occur, requiring immediate medical treatment, and the medication should be stored out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air and moisture, preferably at room temperature between 1 and 30 degrees Celsius. By doing so, the efficacy of the medication can be preserved for a longer time.
Green, oblong tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Youyoung Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.